Literature DB >> 24661180

Reversal of aggregation using β-breaker dipeptide containing peptides: Application to Aβ(1-40) self-assembly and its inhibition.

Krishna Chaitanya Nadimpally1, Ashim Paul, Bhubaneswar Mandal.   

Abstract

Reversion of protein or peptide aggregation is a formidable task, important in various domains of research at the interface of chemistry, medicine, and nanoscience. A novel class of dipeptides, termed as β-breaker dipeptides (BBDPs), is identified, which can be incorporated into the self-recognizing sequences to generate a novel class of conformational switch which forms β-sheet at an initial stage and then converts in a controlled manner to random coil at specific conditions. Incorporation of BBDPs in a well designed amyloidogenic peptides generates a special class of β-sheet breaker peptides those undergo a chemical change at physiological condition generating a breaker element in situ. These β-breaker peptides are shown to first incorporate into the amyloid and then disrupt it. Such conformational switches may be used to study agrregation/disaggregation process and may find many biomedical applications relevant to aggregation related disorders. Such strategy for reversion of peptide aggregation using chemical tricks may find application in material chemistry as well.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24661180      PMCID: PMC4030796          DOI: 10.1021/cn500064z

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  22 in total

1.  Self-assembled monolayers from a designed combinatorial library of de novo beta-sheet proteins.

Authors:  G Xu; W Wang; J T Groves; M H Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.

Authors:  Aphrodite Kapurniotu; Anke Schmauder; Konstantinos Tenidis
Journal:  J Mol Biol       Date:  2002-01-18       Impact factor: 5.469

Review 3.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

4.  Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid.

Authors:  Sharon Gilead; Ehud Gazit
Journal:  Angew Chem Int Ed Engl       Date:  2004-08-06       Impact factor: 15.336

5.  Switch peptides in statu nascendi: induction of conformational transitions relevant to degenerative diseases.

Authors:  Manfred Mutter; Arunan Chandravarkar; Christine Boyat; John Lopez; Sonia Dos Santos; Bhubaneswar Mandal; Richard Mimna; Karine Murat; Luc Patiny; Lydiane Saucède; Gabriele Tuchscherer
Journal:  Angew Chem Int Ed Engl       Date:  2004-08-13       Impact factor: 15.336

6.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

Authors:  J Näslund; V Haroutunian; R Mohs; K L Davis; P Davies; P Greengard; J D Buxbaum
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

7.  Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.

Authors:  J E Maggio; E R Stimson; J R Ghilardi; C J Allen; C E Dahl; D C Whitcomb; S R Vigna; H V Vinters; M E Labenski; P W Mantyh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

9.  Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins.

Authors:  S Clarke
Journal:  Int J Pept Protein Res       Date:  1987-12

Review 10.  Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly.

Authors:  Laramie P Jameson; Nicholas W Smith; Sergei V Dzyuba
Journal:  ACS Chem Neurosci       Date:  2012-08-06       Impact factor: 4.418

View more
  4 in total

1.  Feasibility of β-sheet breaker peptide-H102 treatment for Alzheimer's disease based on β-amyloid hypothesis.

Authors:  Lai-xiang Lin; Xiang-yu Bo; Yuan-zhen Tan; Feng-xian Sun; Ming Song; Juan Zhao; Zhi-hong Ma; Mei Li; Kai-jun Zheng; Shu-Mei Xu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

2.  Disaggregation of Amylin Aggregate by Novel Conformationally Restricted Aminobenzoic Acid containing α/β and α/γ Hybrid Peptidomimetics.

Authors:  Ashim Paul; Sourav Kalita; Sujan Kalita; Piruthivi Sukumar; Bhubaneswar Mandal
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

3.  An explicitly designed paratope of amyloid-β prevents neuronal apoptosis in vitro and hippocampal damage in rat brain.

Authors:  Ashim Paul; Sourav Kumar; Sujan Kalita; Sourav Kalita; Dibakar Sarkar; Anirban Bhunia; Anupam Bandyopadhyay; Amal Chandra Mondal; Bhubaneswar Mandal
Journal:  Chem Sci       Date:  2020-12-22       Impact factor: 9.825

4.  Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity.

Authors:  Ashim Paul; Moran Frenkel-Pinter; Daniela Escobar Alvarez; Giulia Milordini; Ehud Gazit; Elsa Zacco; Daniel Segal
Journal:  Commun Biol       Date:  2020-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.